Serum infliximab levels, antibodies to infliximab and albumin concentrations during infliximab treatment in patients with inflammatory bowel diseases
Abstract
Monitoring of infliximab pharmacokinetics and regular monitoring of antibodies to infliximab may contribute to the disease development and biological treatment effectiveness.